Clinical trial
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving…
NCT00471653 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00471653 |
|---|---|
| Title | Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy |
| Official title | A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Brain and Central Nervous System Tumors, Thrombocytopenia |
| Intervention type | Drug, Genetic, Other, Radiation |
| Interventions | temozolomide, comparative genomic hybridization, polymorphism analysis, laboratory biomarker analysis, pharmacological study, radiation therapy |
| Enrollment | 10 |
| Start date | Nov 11, 2006 |
| Primary completion | Nov 12, 2008 |
| Completion | Aug 18, 2009 |
| First posted | May 10, 2007 |
| Last update posted | Jul 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: